alexa Topical Delivery of Lipid Based Amphotericin B Gel in t
ISSN: 2155-9554

Journal of Clinical & Experimental Dermatology Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Topical Delivery of Lipid Based Amphotericin B Gel in the Treatment of Fungal Infection: A Clinical Efficacy, Safety and Tolerability Study in Patients

Saifuddin Sheikh1, Ateeq Ahmad1, Shoukath M Ali1, Mahesh Paithankar2, Hanmant Barkate2, Ranjan C Raval3, Kalpesh Shah4, Bhavik A Bhavsar5, Radha KR6, Jayaraman AM7,Manish Sharma8 and Imran Ahmad1*

1Jina Pharmaceuticals, Inc. 28100 Ashley Circle, Suite 103, Libertyville, IL, USA

2Intas Pharmaceuticals, Ltd., Ahmedabad, India

3Sheth V.S. General Hospital, Ellisbridge, Ahmedabad, India

4Institute of Cosmetic and Skin care, Paldi, Ahmedabad, India

5Lavanya Skin Clinic, Maninagar, Ahmedabad, India

6Anbu Clinic, Chennai, India

7Skin and Cosmetic Clinic, Chennai, India

8Lambda Therapeutic Research Ltd., Ahmedabad, India

*Corresponding Author:
Imran Ahmad
Jina Pharmaceuticals, Inc. 28100 Ashley Circle
Suite 103, Libertyville, IL, USA
Tel: 847 557 0771
Fax: 847 557 0770
E-mail: [email protected]

Received date: August 29, 2014; Accepted date: November 22, 2014; Published date: November 29, 2014

Citation: Sheikh S, Ahmad A, Ali SM, Paithankar M, Raval RC, et al. (2014) Topical Delivery of Lipid Based Amphotericin B Gel in the Treatment of Fungal Infection: A Clinical Efficacy, Safety and Tolerability Study in Patients. J Clin Exp Dermatol Res 5:248. doi:10.4172/2155-9554.1000248

Copyright: © 2014 Sheikh S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Objectives: A novel topical formulation of lipid based amphotericin B (0.1% amphotericin B Gel) was developed to assess the safety, tolerability and efficacy in adult patients with cutaneous and/or mucocutaneous fungal infection.

Methods: Amphotericin B gel was formulated using lipids. In vitro release assay of amphotericin B was measured using paddle apparatus maintained at 37.0° ± 0.5°C. The stability studies of amphotericin B gel were carried out at 2-8°C, 25°C and 40°C. To test the effect of the drug in clinical setting, 100 patients with recurrent case after failure to standard therapy for cutaneous and/or mucocutaneous fungal infection were treated with amphotericin B Gel. The amphotericin B Gel was applied on the affected area twice daily for 14 days in patients with cutaneous fungal infection and for 7 days in patients of mucocutaneous fungal infection. Response to the amphotericin B Gel treatment was monitored in the patients for up to 14 days and 28 days for mucocutaneous and cutaneous infection respectively.

Results: Based on the stability studies, the recommended shelf life of amphotericin B gel is 24 months at 25°C. In vitro studies showed the release of ~90% amphotericin B within two hours and complete release within four hours. A total of 83 patients were assessed for cutaneous fungal infection where 39 patients were cured, 9 patients showed marked improvement, 26 patients showed moderate improvement and 9 patients showed failure after the treatment. For mucocutaneous fungal infection, 100% patients were cured at the end of the treatment. No serious adverse events were reported in patients during the study.

Conclusion: Lipid based amphotericin B gel in patients with cutaneous and mucocutaneous fungal infections was found to be safe, tolerable and efficacious.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords